[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Animal Parasiticides Market by Type (Ectoparasiticides, Endoparasiticides, Endectocides), Animal Type (Dogs, Cats, Horses, Cattle, Pigs, Poultry, Goats), End User (Veterinary Hospitals, Animal farms, Home Care Settings) - Global Forecast to 2027

March 2023 | 285 pages | ID: A2ECC3371F7EN
MarketsandMarkets

US$ 3,465.00 US$ 4,950.00 -30 %
Offer valid until March 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The market for animal parasiticides is anticipated to grow from USD 10.6 billion in 2022 to USD 14.1 billion in 2027, at a CAGR of 5.8% over the forecast period. The market for animal parasiticides is expanding as a result of factors like the rising demand for food products made from animals, growing private player investments, laws aimed at preventing the spread of animal diseases, and rising costs for animal health care. During the projected period, regulations on the use of parasiticides on animals used for food production and a move toward vegetarianism will likely hamper the growth of this market.

“ectoparasiticides segment was dominated by the highest share in animal parasiticides market”

The animal parasiticides market is divided into endoparasiticides, ectoparasiticides, and endectocides based on type. The ectoparasiticides segment accounted for the highest share of the global animal parasiticides market in 2021. The high adoption of ectoparasiticides relative to other products is responsible for the huge proportion of this market. The rise in ownership of animals and the number of companion animals in developed nations are additional factors that are anticipated to promote market expansion throughout the projected period.

'Companion animals segment is accounted for highest market share in the forecast period.'

The market for animal parasiticides is divided into divisions for companion animals and livestock animals based on the animal type. The companion animals was the largest segment of the global market for animal parasiticides in 2021. Companion animals accounted for the largest share of the global animal parasiticides market in 2021. The significant market share of this sector is largely due to the rising costs of keeping pets and the rise in the number of people who own companion animals in developed countries.

“Veterinary clinics & hospitals segment is expected to witness the fastest growth in the forecast period.”

Animal farms, veterinary clinics & hospitals, and home care settings comprise the end-user segments of the market for animal parasiticides. The fastest growing market for animal parasiticides in 2021 was held by veterinary clinics and hospitals. The increased use of animal parasiticides in medical settings, the rise in parasitic illnesses, and the rising concern over animal health in developing nations are all factors that contribute to the fastest growth of this segment.

'Latin America is expected to witness the fastest growth in the forecast period.'

In the forecast period, Latin America in the animal parasiticides market will have the fastest rising regional growth. Rising numbers of companion and food-producing animals, as well as the region's rising demand for food items generated from animals, are the main factors driving market growth. Several countries in Latin America are significant suppliers of beef to the global market. China has been recognized as the primary market for Brazilian beef exports, despite an increase in volume and overall value over the previous year. In the upcoming years, it is anticipated that a rise in beef exports from Latin American nations would support a rise in the market for animal parasiticides in this area.

Following is a list of the major players (supply-side) in the animal parasiticides market that this study refers to:
  • By Company Type: Tier 1- 34%, Tier 2- 46%, and Tier 3- 20%
  • By Designation: C-level- 35%, Director Level—25%, and Others- 40%
  • By Region: North America-30%, Europe-45%, Asia Pacific-20%, Latin America- 3%, and Middle East and Africa-2%
Several of the major companies in the market for animal parasiticides include Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Ceva Sant? Animale (France), Vetoquinol S.A. (France), PetIQ, Inc. (US), Norbrook (Ireland), and Bimeda Animal Health (Ireland).

Research Coverage:

The market study analyzes the main market segments for animal parasiticides. The objective of this study is to estimate the market's size and growth potential across several categories according to kind, animal type, end user, and region. The report also provides a thorough competition analysis of the major market participants, together with company profiles, major insights regarding their product and service offerings, recent advancements, and key market strategies.

Key Benefits of Buying the Report:

The study provides data regarding the animal parasiticides market's closest approximations and its segments, which will benefit market leaders and new entrants. This study will assist stakeholders in comprehending the competitive environment, obtaining insights to better position of their businesses, and developing appropriate go-to-market strategies. The research will also assist stakeholders in obtaining insights into the market's pulse and learning about its major drivers, inhibitors, opportunities, and problems.

The report provides insights on the following pointers:

Analysis of key drivers (Rising demand for animal-derived food products, Growing prevalence of animal diseases, Regulations for preventing spread of animal diseases), restraints (Regulations restricting use of parasiticides for food-producing animals), opportunities (Lucrative growth opportunities in emerging markets), and challenges (Stringent regulatory approval process for drugs) influencing the growth of the Animal parasiticide market.

Product Development/innovation:

Comprehensive details on new technologies, R&D initiatives, and product and service launches for animal parasiticides market

Market Development:

Comprehensive data on attractive markets, and the research analyzes the global animal parasiticides market.

Market Diversification:

Detailed information on emerging products and services, unexplored regions, current trends, and investments in the animal parasiticide market.

Competitive Assessment:

Comprehensive analysis of market shares, growth plans, and service offerings of major companies operating in the animal parasiticide market like Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Ceva Sant? Animale (France), Vetoquinol S.A. (France), PetIQ, Inc. (US), Norbrook (Ireland), and Bimeda Animal Health (Ireland).
1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
  1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
FIGURE 1 ANIMAL PARASITICIDES MARKET SEGMENTATION
FIGURE 2 ANIMAL PARASITICIDES MARKET, BY REGION
  1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
  1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

2.1 RESEARCH APPROACH
FIGURE 3 RESEARCH DESIGN
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
FIGURE 4 PRIMARY SOURCES
    2.1.2.1 Key data from primary sources
    2.1.2.2 Key industry insights
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 8 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: ZOETIS INC.
FIGURE 10 SUPPLY-SIDE ANALYSIS: ANIMAL PARASITICIDES MARKET (2021)
FIGURE 11 COUNTRY-LEVEL ANALYSIS OF ANIMAL PARASITICIDES MARKET
FIGURE 12 BOTTOM-UP APPROACH
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ANIMAL PARASITICIDES MARKET (2022–2027): IMPACT ON MARKET GROWTH AND CAGR
FIGURE 14 CAGR PROJECTIONS
FIGURE 15 TOP-DOWN APPROACH
2.3 LIMITATIONS
  2.3.1 METHODOLOGY-RELATED LIMITATIONS
  2.3.2 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 16 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS
2.6 RISK ASSESSMENT/LIMITATIONS
2.7 IMPACT OF RECESSION

3 EXECUTIVE SUMMARY

FIGURE 17 ANIMAL PARASITICIDES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 18 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 19 ANIMAL PARASITICIDES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF ANIMAL PARASITICIDES MARKET

4 PREMIUM INSIGHTS

4.1 ANIMAL PARASITICIDES MARKET OVERVIEW
FIGURE 21 GROWING PREVALENCE OF ANIMAL DISEASES AND RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET
4.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE AND COUNTRY (2021)
FIGURE 22 ECTOPARASITICIDES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ANIMAL PARASITICIDES MARKET IN 2021
4.3 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.4 ANIMAL PARASITICIDES MARKET: REGIONAL MIX
FIGURE 24 NORTH AMERICA TO CONTINUE TO DOMINATE ANIMAL PARASITICIDES MARKET IN 2027
4.5 ANIMAL PARASITICIDES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
FIGURE 25 DEVELOPING COUNTRIES TO OFFER GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 26 ANIMAL PARASITICIDES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  5.2.1 DRIVERS
    5.2.1.1 Rising demand for animal-derived food products
FIGURE 27 WORLD MILK PRODUCTION ESTIMATES (2021–2030)
FIGURE 28 WORLD MEAT PRODUCTION ESTIMATES (2021–2030)
    5.2.1.2 Increasing investments by private players
    5.2.1.3 Growing concerns of zoonotic diseases
    5.2.1.4 Regulations for preventing spread of animal diseases
    5.2.1.5 Growing companion animal ownership rates
FIGURE 29 EUROPE: PET POPULATION
    5.2.1.6 Growing prevalence of animal diseases
    5.2.1.7 Rising animal health expenditure
FIGURE 30 US: INCREASING PET EXPENDITURE, 2010–2021 (USD BILLION)
FIGURE 31 EUROPE: ANNUAL VALUE OF PET-RELATED PRODUCTS, 2010–2021 (EUR BILLION)
  5.2.2 RESTRAINTS
    5.2.2.1 Regulations restricting use of parasiticides for food-producing animals
    5.2.2.2 Shift toward vegetarianism
    5.2.2.3 Novel drug development models
  5.2.3 OPPORTUNITIES
    5.2.3.1 Lucrative growth opportunities in emerging markets
  5.2.4 CHALLENGES
    5.2.4.1 Growing resistance to parasiticides
TABLE 1 PARASITICIDES AND RESISTANT PARASITES
    5.2.4.2 Stringent regulatory approval process for drugs
    5.2.4.3 Diversity in parasite species
5.3 PRICING ANALYSIS
  5.3.1 AVERAGE SELLING PRICE OF ANIMAL PARASITICIDES, BY TYPE
TABLE 2 AVERAGE SELLING PRICE OF ANIMAL PARASITICIDES, BY TYPE (USD)
  5.3.2 AVERAGE SELLING PRICE TRENDS
5.4 SUPPLY CHAIN ANALYSIS
FIGURE 32 SUPPLY CHAIN ANALYSIS: ANIMAL PARASITICIDES MARKET
5.5 ECOSYSTEM ANALYSIS
FIGURE 33 ECOSYSTEM ANALYSIS: ANIMAL PARASITICIDES MARKET
5.6 PATENT ANALYSIS
FIGURE 34 PATENT PUBLICATION TRENDS (JANUARY 2013–FEBRUARY 2023)
  5.6.1 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR ANIMAL PARASITICIDES
FIGURE 35 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR ANIMAL PARASITICIDE PATENTS (2013–2023)
5.7 VALUE CHAIN ANALYSIS
FIGURE 36 VALUE CHAIN ANALYSIS: ANIMAL PARASITICIDES MARKET
5.8 CASE STUDIES
FIGURE 37 CASE STUDY: MARKET ASSESSMENT FOR COMPANION ANIMALS
FIGURE 38 CASE STUDY: OPPORTUNITY ANALYSIS FOR BROAD-SPECTRUM PARASITICIDES
5.9 REGULATORY ANALYSIS
  5.9.1 REGULATORY LANDSCAPE
TABLE 3 US: RECENT DEVELOPMENTS IN REGULATIONS FOR VETERINARY DRUGS
  5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.9.2.1 North America
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.9.2.2 Europe
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.9.2.3 Asia Pacific and Rest of the World
TABLE 6 ASIA PACIFIC AND REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 PORTER’S FIVE FORCES ANALYSIS: ANIMAL PARASITICIDES MARKET (2021)
  5.10.1 INTENSITY OF COMPETITIVE RIVALRY
  5.10.2 BARGAINING POWER OF SUPPLIERS
  5.10.3 BARGAINING POWER OF BUYERS
  5.10.4 THREAT OF NEW ENTRANTS
  5.10.5 THREAT OF SUBSTITUTES
5.11 ADJACENT MARKET ANALYSIS
FIGURE 39 ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET: MARKET OVERVIEW
5.12 KEY CONFERENCES AND EVENTS DURING 2023–2024
TABLE 8 ANIMAL PARASITICIDES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 40 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF ANIMAL PARASITICIDES
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF ANIMAL PARASITICIDES
  5.13.2 BUYING CRITERIA
TABLE 10 KEY BUYING CRITERIA FOR TOP THREE TYPES OF ANIMAL PARASITICIDES
5.14 TRADE ANALYSIS
5.15 INDUSTRY TRENDS
  5.15.1 GROWING CONSOLIDATION IN ANIMAL HEALTH INDUSTRY
TABLE 11 MAJOR ACQUISITIONS IN ANIMAL PARASITICIDES INDUSTRY (2019–2021)
  5.15.2 INNOVATIONS IN ANIMAL PARASITICIDES
TABLE 12 INNOVATIVE ANIMAL PHARMACEUTICAL TRENDS
5.16 IMPACT OF INFLATION AND RECESSION ON ANIMAL PARASITICIDES MARKET

6 ANIMAL PARASITICIDES MARKET, BY TYPE

6.1 INTRODUCTION
TABLE 13 ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 14 ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2 ECTOPARASITICIDES
TABLE 15 EXAMPLES OF ECTOPARASITICIDES AVAILABLE IN MARKET
TABLE 16 ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 17 ECTOPARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.2.1 POUR-ONS & SPOT-ONS
    6.2.1.1 Ease of application to support adoption
TABLE 18 POUR-ONS & SPOT-ONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.2.2 ORAL TABLETS
    6.2.2.1 High medication compliance and ease of administration to drive market
TABLE 19 ORAL TABLETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.2.3 SPRAYS
    6.2.3.1 Low price and convenience to drive market
TABLE 20 SPRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.2.4 DIPS
    6.2.4.1 High popularity ensured sustained end-user demand
TABLE 21 DIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.2.5 EAR TAGS
    6.2.5.1 Highly effective in controlling flies around cattle
TABLE 22 EAR TAGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.2.6 COLLARS
    6.2.6.1 Growing prevalence of infections in companion animals to drive adoption
TABLE 23 COLLARS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.2.7 OTHER ECTOPARASITICIDES
TABLE 24 OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 ENDOPARASITICIDES
TABLE 25 EXAMPLES OF ENDOPARASITICIDES AVAILABLE IN MARKET
TABLE 26 ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 27 ENDOPARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.3.1 ORAL LIQUIDS
    6.3.1.1 Growing demand for meat and milk products to drive market
TABLE 28 ORAL LIQUIDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.3.2 ORAL SOLIDS
    6.3.2.1 Emergence of internal parasitic infections in dogs to drive market
TABLE 29 ORAL SOLIDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.3.3 INJECTABLES
    6.3.3.1 Mostly used in food-producing animals
TABLE 30 INJECTABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.3.4 FEED ADDITIVES
    6.3.4.1 Can be administered to large number of animals at once
TABLE 31 FEED ADDITIVES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  6.3.5 OTHER ENDOPARASITICIDES
TABLE 32 OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 ENDECTOCIDES
  6.4.1 POTENTIAL TO TREAT BOTH INTERNAL AND EXTERNAL PARASITE INFECTIONS
TABLE 33 EXAMPLES OF ENDECTOCIDES AVAILABLE IN MARKET
TABLE 34 ENDECTOCIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE

7.1 INTRODUCTION
TABLE 35 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
7.2 COMPANION ANIMALS
TABLE 36 COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 37 COMPANION ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  7.2.1 DOGS
    7.2.1.1 Most adopted companion animals
TABLE 38 COMPANION ANIMAL PARASITICIDES MARKET FOR DOGS, BY COUNTRY, 2020–2027 (USD MILLION)
  7.2.2 CATS
    7.2.2.1 High vulnerability to parasitic infections to support market growth
TABLE 39 COMPANION ANIMAL PARASITICIDES MARKET FOR CATS, BY COUNTRY, 2020–2027 (USD MILLION)
  7.2.3 HORSES
    7.2.3.1 Rising need for equine parasitic control to drive market
TABLE 40 HORSE POPULATION, BY REGION, 2016–2019 (MILLION)
TABLE 41 COMPANION ANIMAL PARASITICIDES MARKET FOR HORSES, BY COUNTRY, 2020–2027 (USD MILLION)
  7.2.4 OTHER COMPANION ANIMALS
TABLE 42 OTHER COMPANION ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 LIVESTOCK
FIGURE 41 PRODUCTION OF MEAT WORLDWIDE, BY TYPE, 2016–2020
TABLE 43 LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 44 LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
  7.3.1 CATTLE
    7.3.1.1 Susceptible to parasitic infestations and diseases due to internal parasites
TABLE 45 LIVESTOCK PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2020–2027 (USD MILLION)
  7.3.2 PIGS
    7.3.2.1 Growing pork consumption to drive demand for parasiticides
TABLE 46 LIVESTOCK PARASITICIDES MARKET FOR PIGS, BY COUNTRY, 2020–2027 (USD MILLION)
  7.3.3 POULTRY
    7.3.3.1 Growing egg consumption in emerging countries to drive demand for parasiticides
FIGURE 42 LEADING EGG-PRODUCING COUNTRIES WORLDWIDE, 2019
TABLE 47 LIVESTOCK PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2020–2027 (USD MILLION)
  7.3.4 SHEEP & GOATS
    7.3.4.1 Growth in consumption of sheep and goat meat to drive market
TABLE 48 LIVESTOCK PARASITICIDES MARKET FOR SHEEP & GOATS, BY COUNTRY, 2020–2027 (USD MILLION)
  7.3.5 OTHER LIVESTOCK
TABLE 49 OTHER LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

8 ANIMAL PARASITICIDES MARKET, BY END USER

8.1 INTRODUCTION
TABLE 50 ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 VETERINARY HOSPITALS AND CLINICS
  8.2.1 HIGH ADOPTION OF ANIMAL PARASITICIDES IN VETERINARY HOSPITALS AND CLINICS TO DRIVE MARKET
TABLE 51 ANIMAL PARASITICIDES MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 ANIMAL FARMS
  8.3.1 INCREASING INCIDENCE OF PARASITIC INFECTIONS IN LIVESTOCK TO SUPPORT MARKET GROWTH
TABLE 52 ANIMAL PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 HOME CARE SETTINGS
  8.4.1 RISING PET OWNERSHIP AND AWARENESS TO DRIVE MARKET
TABLE 53 ANIMAL PARASITICIDES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION)

9 ANIMAL PARASITICIDES MARKET, BY REGION

9.1 INTRODUCTION
FIGURE 43 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 54 ANIMAL PARASITICIDES MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 44 NORTH AMERICA: ANIMAL PARASITICIDES MARKET SNAPSHOT
  9.2.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN NORTH AMERICA
TABLE 55 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 56 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 NORTH AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 58 NORTH AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 59 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 60 NORTH AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 61 NORTH AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 62 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.2.2 US
    9.2.2.1 Rising pet expenditure and increasing meat consumption to drive market
FIGURE 45 US: PET ADOPTION DURING COVID-19 PANDEMIC
FIGURE 46 US: INCREASE IN PET EXPENDITURE, 2011–2021 (USD BILLION)
FIGURE 47 US: BEEF CONSUMPTION, 2011–2021 (BILLION POUNDS)
TABLE 63 US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2018 VS. 2019 VS. 2020
TABLE 64 US: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 US: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 66 US: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 US: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 68 US: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 69 US: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 70 US: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.2.3 CANADA
    9.2.3.1 Growing pet adoption to support market growth
TABLE 71 CANADA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 CANADA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 CANADA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 CANADA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 75 CANADA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 76 CANADA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 77 CANADA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 78 EUROPE: LIVESTOCK POPULATION, BY TYPE, 2011–2021 (MILLION)
  9.3.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN EUROPE
TABLE 79 EUROPE: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 84 EUROPE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 85 EUROPE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 86 EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.3.2 GERMANY
    9.3.2.1 Growing demand for quality animal-derived food products to drive market
TABLE 87 GERMANY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 GERMANY: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 GERMANY: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 90 GERMANY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 91 GERMANY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 92 GERMANY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 93 GERMANY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.3.3 UK
    9.3.3.1 Increasing pet ownership to drive market
TABLE 94 UK: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 UK: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 UK: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 UK: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 98 UK: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 99 UK: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 100 UK: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.3.4 FRANCE
    9.3.4.1 Presence of major market players to propel market growth
TABLE 101 FRANCE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 FRANCE: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 FRANCE: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 FRANCE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 105 FRANCE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 106 FRANCE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 107 FRANCE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.3.5 SPAIN
    9.3.5.1 Increasing animal health expenditure to drive market
TABLE 108 SPAIN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 SPAIN: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 SPAIN: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 SPAIN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 112 SPAIN: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 113 SPAIN: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 114 SPAIN: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.3.6 ITALY
    9.3.6.1 Need to curb zoonotic diseases in livestock to propel market
TABLE 115 ITALY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 ITALY: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 ITALY: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 ITALY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 119 ITALY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 120 ITALY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 121 ITALY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.3.7 REST OF EUROPE
FIGURE 48 NETHERLANDS: NUMBER OF DAIRY COWS, 2011–2020 (THOUSAND)
TABLE 122 REST OF EUROPE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2021 (MILLION)
TABLE 123 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 REST OF EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 REST OF EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 127 REST OF EUROPE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 128 REST OF EUROPE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 129 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 49 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET SNAPSHOT
  9.4.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN ASIA PACIFIC
TABLE 130 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 131 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 135 ASIA PACIFIC: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 136 ASIA PACIFIC: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 137 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.4.2 CHINA
    9.4.2.1 Increasing pet expenditure and companion animal ownership to propel market
FIGURE 50 CHINA: CONSUMPTION OF PORK PRODUCTS PER CAPITA, 2011–2021 (KILOGRAMS)
TABLE 138 CHINA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 CHINA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 CHINA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 CHINA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 142 CHINA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 143 CHINA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 144 CHINA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.4.3 AUSTRALIA & NEW ZEALAND
    9.4.3.1 Rising livestock population and increasing awareness about parasitic infections to drive market
TABLE 145 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 146 AUSTRALIA & NEW ZEALAND: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 AUSTRALIA & NEW ZEALAND: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 149 AUSTRALIA & NEW ZEALAND: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 150 AUSTRALIA & NEW ZEALAND: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 151 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.4.4 JAPAN
    9.4.4.1 Rising pet care expenditure to propel market
TABLE 152 JAPAN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 JAPAN: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 JAPAN: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 JAPAN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 156 JAPAN: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 157 JAPAN: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 158 JAPAN: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.4.5 INDIA
    9.4.5.1 Rising demand for animal-derived food products to support market growth
TABLE 159 INDIA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 INDIA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 INDIA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 INDIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 163 INDIA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 164 INDIA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 165 INDIA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.4.6 SOUTH KOREA
    9.4.6.1 Rising investments in animal healthcare infrastructure to propel market
TABLE 166 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 167 SOUTH KOREA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 SOUTH KOREA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 170 SOUTH KOREA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 171 SOUTH KOREA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 172 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.4.7 REST OF ASIA PACIFIC
TABLE 173 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 REST OF ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 REST OF ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 176 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 177 REST OF ASIA PACIFIC: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 178 REST OF ASIA PACIFIC: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 179 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
  9.5.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN LATIN AMERICA
TABLE 180 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 181 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 182 LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 183 LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 185 LATIN AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 186 LATIN AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 187 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.5.2 BRAZIL
    9.5.2.1 Growing prevalence of zoonotic diseases to drive market
TABLE 188 BRAZIL: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 189 BRAZIL: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 BRAZIL: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 191 BRAZIL: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 192 BRAZIL: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 193 BRAZIL: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 194 BRAZIL: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.5.3 REST OF LATIN AMERICA
TABLE 195 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 196 REST OF LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 197 REST OF LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 198 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 199 REST OF LATIN AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 200 REST OF LATIN AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 201 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
  9.6.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN MIDDLE EAST AND AFRICA
TABLE 202 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 203 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 204 MIDDLE EAST AND AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 205 MIDDLE EAST AND AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 206 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 207 MIDDLE EAST AND AFRICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 208 MIDDLE EAST AND AFRICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 209 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.6.2 TURKEY
    9.6.2.1 Increase in companion animal population to drive market
TABLE 210 TURKEY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 TURKEY: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 212 TURKEY: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 213 TURKEY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 214 TURKEY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 215 TURKEY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 216 TURKEY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)
  9.6.3 REST OF MIDDLE EAST AND AFRICA
TABLE 217 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 218 REST OF MIDDLE EAST AND AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 219 REST OF MIDDLE EAST AND AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 220 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 221 REST OF MIDDLE EAST AND AFRICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 222 REST OF MIDDLE EAST AND AFRICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 223 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES
FIGURE 51 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN ANIMAL PARASITICIDES MARKET
10.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN ANIMAL PARASITICIDES MARKET
FIGURE 52 REVENUE ANALYSIS FOR KEY PLAYERS IN ANIMAL PARASITICIDES MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 53 ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
TABLE 224 ANIMAL PARASITICIDES MARKET: DEGREE OF COMPETITION
10.5 R&D ASSESSMENT OF KEY PLAYERS
10.6 COMPANY EVALUATION QUADRANT
FIGURE 54 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX, 2021
  10.6.1 STARS
  10.6.2 PERVASIVE PLAYERS
  10.6.3 EMERGING LEADERS
  10.6.4 PARTICIPANTS
10.7 COMPETITIVE LEADERSHIP MAPPING FOR SMES AND STARTUPS
FIGURE 55 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX FOR SMES AND STARTUPS, 2021
  10.7.1 PROGRESSIVE COMPANIES
  10.7.2 DYNAMIC COMPANIES
  10.7.3 STARTING BLOCKS
  10.7.4 RESPONSIVE COMPANIES
10.8 COMPETITIVE BENCHMARKING
  10.8.1 OVERALL COMPANY FOOTPRINT
TABLE 225 OVERALL COMPANY FOOTPRINT
TABLE 226 COMPANY FOOTPRINT ANALYSIS, BY TYPE
TABLE 227 COMPANY FOOTPRINT ANALYSIS, BY ANIMAL TYPE
TABLE 228 COMPANY FOOTPRINT ANALYSIS, BY END USER
TABLE 229 COMPANY FOOTPRINT ANALYSIS, BY REGION
10.9 COMPETITIVE SCENARIO
  10.9.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 230 PRODUCT LAUNCHES AND APPROVALS, JANUARY 2019–FEBRUARY 2023
  10.9.2 DEALS
TABLE 231 DEALS, JANUARY 2019–FEBRUARY 2023
  10.9.3 OTHER DEVELOPMENTS
TABLE 232 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2023

11 COMPANY PROFILES

11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
  11.1.1 BOEHRINGER INGELHEIM GMBH
TABLE 233 BOEHRINGER INGELHEIM GMBH: BUSINESS OVERVIEW
FIGURE 56 BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT (2021)
  11.1.2 ZOETIS INC.
TABLE 234 ZOETIS INC.: BUSINESS OVERVIEW
FIGURE 57 ZOETIS INC.: COMPANY SNAPSHOT (2021)
  11.1.3 ELANCO ANIMAL HEALTH INCORPORATED
TABLE 235 ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW
FIGURE 58 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2021)
  11.1.4 MERCK & CO., INC
TABLE 236 MERCK & CO., INC.: BUSINESS OVERVIEW
FIGURE 59 MERCK & CO., INC.: COMPANY SNAPSHOT (2021)
  11.1.5 VIRBAC
TABLE 237 VIRBAC: BUSINESS OVERVIEW
FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2021)
  11.1.6 VETOQUINOL S.A.
TABLE 238 VETOQUINOL S.A.: BUSINESS OVERVIEW
FIGURE 61 VETOQUINOL S.A.: COMPANY SNAPSHOT (2021)
  11.1.7 PETIQ, LLC
TABLE 239 PETIQ, LLC: BUSINESS OVERVIEW
FIGURE 62 PETIQ, LLC: COMPANY SNAPSHOT (2021)
  11.1.8 SEQUENT SCIENTIFIC LIMITED
TABLE 240 SEQUENT SCIENTIFIC LIMITED: BUSINESS OVERVIEW
FIGURE 63 SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT (2021)
  11.1.9 KRKA GROUP
TABLE 241 KRKA GROUP: BUSINESS OVERVIEW
FIGURE 64 KRKA GROUP: COMPANY SNAPSHOT (2021)
  11.1.10 ECO ANIMAL HEALTH GROUP PLC
TABLE 242 ECO ANIMAL HEALTH GROUP PLC: BUSINESS OVERVIEW
FIGURE 65 ECO ANIMAL HEALTH GROUP PLC: COMPANY SNAPSHOT (2021)
11.2 OTHER PLAYERS
  11.2.1 CEVA SANT? ANIMALE
TABLE 243 CEVA SANT? ANIMALE: BUSINESS OVERVIEW
  11.2.2 CHANELLE PHARMA
TABLE 244 CHANELLE PHARMA: BUSINESS OVERVIEW
  11.2.3 BIMEDA ANIMAL HEALTH
TABLE 245 BIMEDA ANIMAL HEALTH: BUSINESS OVERVIEW
  11.2.4 NORBROOK
TABLE 246 NORBROOK: BUSINESS OVERVIEW
  11.2.5 KYORITSU SEIYAKU CORPORATION
TABLE 247 KYORITSU SEIYAKU CORPORATION: BUSINESS OVERVIEW
  11.2.6 SMARTVET HOLDINGS, INC.
TABLE 248 SMARTVET HOLDINGS, INC.: BUSINESS OVERVIEW
  11.2.7 UCBVET
TABLE 249 UCBVET: BUSINESS OVERVIEW
  11.2.8 CALIER
TABLE 250 CALIER: BUSINESS OVERVIEW
  11.2.9 ABBEY ANIMAL HEALTH PTY LTD.
TABLE 251 ABBEY ANIMAL HEALTH PTY LTD.: BUSINESS OVERVIEW
  11.2.10 BIOG?NESIS BAG?
TABLE 252 BIOG?NESIS BAG?: BUSINESS OVERVIEW
  11.2.11 PRN PHARMACAL
TABLE 253 PRN PHARMACAL: BUSINESS OVERVIEW
  11.2.12 LUTIM PHARMA PRIVATE LIMITED
TABLE 254 LUTIM PHARMA PRIVATE LIMITED: BUSINESS OVERVIEW
  11.2.13 VETANCO SA
TABLE 255 VETANCO SA: BUSINESS OVERVIEW
  11.2.14 BRILLIANT BIO PHARMA
TABLE 256 BRILLIANT BIO PHARMA: BUSINESS OVERVIEW
  11.2.15 ZUCHE PHARMACEUTICALS PVT. LTD.
TABLE 257 ZUCHE PHARMACEUTICALS PVT. LTD.: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS

The global animal parasiticides market was valued at $XX million in 2013 and is expected to reach $XX million by 2018, growing at a CAGR of XX% from 2013 to 2018. This market is consolidated in  nature. The  top  five market  players—Sanofi (France), Bayer  AG  (Germany), Zoetis, Inc. (U.S.), Novartis AG (Switzerland), and Merck & Co., Inc. (U.S.)—had a collective market share of nearly XX% in 2013. Some of the other leading players in the industry include Ceva  Sante  Animale  (France),  Virbac  SA  (France),  Boehringer  Ingelheim  (Germany),  and Vetoquinol  (France).  Together,  the  top  10  players  accounted  for  approximately  XX%  of  the global animal parasiticides market in 2013. 

Currently, this market is driven by the rising concerns regarding zoonotic diseases, upsurge in the  investment  from  government  organizations,  non-government  agencies,  leading  market players,  increasing  demand  for  animal  protein  and  animal-based  food,  and  worldwide regulations  for  prevention  of  the  spread  of  animal  diseases.  In  addition,  implementation  of animal welfare acts in developed countries, broad spectrum of parasiticides product offerings by leading players, and upsurge in the adoption of pet animals are also expected to drive the sales volume of the animal parasiticides market during the forecast period. 

In  terms  of  geographic  focus,  the  market  will  experience  an  increase  in  the  high-growth developing  markets  across  APAC  and  the  RoW  regions.  Though  Europe  and  North  America commanded  the  largest  share  in  the  animal  parasiticides  market  in  2013,  the  emerging countries  in  APAC  and  the  RoW  regions  represent  the  fastest-growing  markets  due  to  the increasing livestock and companion animals population, increasing GDP rate, increase in per capita  animal  health  expenditure,  growing  awareness  about  animal  health  among  animal owners, and improving animal healthcare infrastructure.   

Regulatory restrictions pose a major challenge for the growth of the global animal parasiticides market.  In  the  developed  countries  there  are  stringent  regulations  for  registration  and approval of animal parasiticides which increases the cost and approval time for launching a new product in the market. Moreover, certain parasiticides are banned in some countries for use in certain animal categories.

Currently, the R&D investments in animal pharmaceuticals including parasiticides market are on rise. Mergers and acquisitions among key market players in the animal healthcare market have led to the consolidation of the market. Moreover, the market players are developing a broad  spectrum  of  animal  parasiticides  products  to  combat  the  disease  outbreaks  in  the animals, thereby protecting animal health. These represent the largest trends in the animal parasiticides  market,  attracting  the  largest  share  of  innovation  and  investments  in  the  industry.  

The  animal  parasiticides  market  is  broadly  classified  according  to  product  type  and  animal type.



More Publications